Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials.

MLA

Duell, P.Barton, et al. “Efficacy and Safety of Bempedoic Acid in Patients with Heterozygous Familial Hypercholesterolemia: Analysis of Pooled Patient-Level Data from Phase 3 Clinical Trials.” Journal of Clinical Lipidology, vol. 18, no. 2, Mar. 2024, pp. e153–65. EBSCOhost, https://doi.org/10.1016/j.jacl.2023.12.005.

APA

Duell, P. B., Banach, M., Catapano, A. L., Laufs, U., Mancini, G. B. J., Ray, K. K., Broestl, C., Zhang, Y., Lei, L., & Goldberg, A. C. (2024). Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials. Journal of Clinical Lipidology, 18(2), e153–e165. https://doi.org/10.1016/j.jacl.2023.12.005

Chicago

Duell, P Barton, Maciej Banach, Alberico L Catapano, Ulrich Laufs, G B John Mancini, Kausik K Ray, Christine Broestl, Yang Zhang, Lei Lei, and Anne C Goldberg. 2024. “Efficacy and Safety of Bempedoic Acid in Patients with Heterozygous Familial Hypercholesterolemia: Analysis of Pooled Patient-Level Data from Phase 3 Clinical Trials.” Journal of Clinical Lipidology 18 (2): e153–65. doi:10.1016/j.jacl.2023.12.005.